ALLISON LOFTUS: Open Payments
NPI 1497222541 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,185 in 91 payments from 24 companies in 2025. Trend: 2023 $1,990 · 2024 $1,633 · 2025 $2,185
Food & beverage: $2,185
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 17 | $500 |
| PFIZER INC. | 14 | $262 |
| Novartis Pharmaceuticals Corporation | 5 | $222 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $201 |
| Janssen Biotech, Inc. | 8 | $164 |
| Blue Earth Diagnostics | 5 | $99 |
| Merck Sharp & Dohme LLC | 3 | $89 |
| Astellas Pharma US Inc | 3 | $83 |
| Ferring Pharmaceuticals Inc. | 2 | $71 |
| UROGEN PHARMA, INC. | 3 | $70 |
Products named: PROVENGE, XTANDI, PLUVICTO, Nubeqa, ERLEADA, POSLUMA, ADSTILADRIN, KEYTRUDA.
Industry payments across KS — which companies pay providers there.
